SEPN
Septerna, Inc.
Company overview
- Market capitalization
- $1.85B
- Employees
- 130
- Latest publication
- 2026-09-29
About Septerna, Inc.
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 26,746,000USD | 26,523,000USD | 24,118,000USD | 21,495,000USD | 119,000USD | 219,000USD | 212,000USD | 176,000USD |
| Research Development | 35,132,000USD | 29,114,000USD | 31,861,000USD | 24,264,000USD | 22,188,000USD | 19,271,000USD | 19,317,000USD | 17,832,000USD |
| Total Operating Expenses | 43,582,000USD | 39,402,000USD | 40,141,000USD | 18,881,000USD | 29,097,000USD | 26,129,000USD | 24,930,000USD | 22,726,000USD |
| Income Tax Expense | 973,000USD | 337,000USD | 12,000USD | — | — | — | -160,000USD | -136,000USD |
| Net Income | -13,034,000USD | -8,637,000USD | -10,738,000USD | 8,173,000USD | -24,838,000USD | -21,476,000USD | -20,668,000USD | -20,523,000USD |
| Cost Of Revenue | — | 421,000USD | 401,000USD | — | — | — | — | — |
| Gross Profit | — | 26,102,000USD | 24,118,000USD | 21,495,000USD | 119,000USD | 219,000USD | 212,000USD | 176,000USD |
| Selling General Administrative | — | 10,288,000USD | 8,280,000USD | 7,117,000USD | 6,909,000USD | 6,858,000USD | 5,613,000USD | 4,894,000USD |
| Operating Income | — | -13,300,000USD | -16,023,000USD | 2,614,000USD | -28,978,000USD | -25,910,000USD | -24,718,000USD | -22,550,000USD |
| Interest Income | — | 5,031,000USD | 5,338,000USD | 5,565,000USD | 4,165,000USD | 4,462,000USD | 3,908,000USD | 1,900,000USD |
| Net Interest Income | — | 5,031,000USD | 5,338,000USD | 5,565,000USD | 4,165,000USD | 4,462,000USD | 3,908,000USD | 1,900,000USD |
| Income Before Tax | — | -8,300,000USD | -10,726,000USD | 8,173,000USD | -24,838,000USD | -21,476,000USD | -20,828,000USD | -20,659,000USD |
| Tax Provision | — | 337,000USD | 12,000USD | 0USD | 0USD | 0USD | -160,000USD | -136,000USD |
| Net Income From Continuing Ops | — | -8,637,000USD | -10,738,000USD | 8,173,000USD | -24,838,000USD | -21,476,000USD | -20,668,000USD | -20,523,000USD |
| Ebit | — | -13,300,000USD | -16,023,000USD | -9,886,000USD | -28,978,000USD | -25,910,000USD | -24,718,000USD | -22,550,000USD |
| Ebitda | — | -12,879,000USD | -15,622,000USD | -9,485,000USD | -28,573,000USD | -25,513,000USD | -24,330,000USD | -22,186,000USD |
| Depreciation And Amortization | — | 421,000USD | 401,000USD | 401,000USD | 405,000USD | 397,000USD | 388,000USD | 364,000USD |
| Reconciled Depreciation | — | 421,000USD | 401,000USD | 401,000USD | 405,000USD | 397,000USD | 388,000USD | 364,000USD |
| Total Other Income Expense Net | — | 5,000,000USD | 5,297,000USD | 5,559,000USD | 4,140,000USD | 4,434,000USD | 3,890,000USD | 1,891,000USD |
| Unclassified Operating Expenses | — | — | — | -12,500,000USD | — | — | — | — |
| Source | 0001193125-26-342328Preliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 45,951,000USD | 1,075,000USD | 151,000USD | 0USD |
| Cost Of Revenue | 1,604,000USD | — | — | — |
| Gross Profit | 45,951,000USD | 1,075,000USD | 151,000USD | — |
| Research Development | 97,584,000USD | 65,337,000USD | 35,979,000USD | 22,044,000USD |
| Selling General Administrative | 29,164,000USD | 16,561,000USD | 9,722,000USD | 5,923,000USD |
| Total Operating Expenses | 126,748,000USD | 81,898,000USD | -1,924,000USD | 27,967,000USD |
| Operating Income | -80,797,000USD | -80,823,000USD | 2,075,000USD | -27,967,000USD |
| Interest Income | 19,530,000USD | 8,617,000USD | 2,786,000USD | 291,000USD |
| Net Interest Income | 19,530,000USD | 8,617,000USD | 2,786,000USD | 291,000USD |
| Income Before Tax | -48,867,000USD | -72,296,000USD | 4,871,000USD | -27,676,000USD |
| Income Tax Expense | 12,000USD | -498,000USD | 691,000USD | — |
| Tax Provision | 12,000USD | -498,000USD | 691,000USD | 0USD |
| Net Income | -48,879,000USD | -71,798,000USD | 4,180,000USD | -27,676,000USD |
| Net Income From Continuing Ops | -48,879,000USD | -71,798,000USD | 4,180,000USD | -27,676,000USD |
| Ebit | -80,797,000USD | -80,823,000USD | -45,550,000USD | -27,967,000USD |
| Ebitda | -79,193,000USD | -79,422,000USD | -44,702,000USD | -27,390,000USD |
| Depreciation And Amortization | 1,604,000USD | 1,401,000USD | 848,000USD | 577,000USD |
| Reconciled Depreciation | 1,604,000USD | 1,401,000USD | 848,000USD | 577,000USD |
| Total Other Income Expense Net | 31,930,000USD | 8,527,000USD | 2,796,000USD | 291,000USD |
| Unclassified Operating Expenses | — | — | -47,625,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 566,737,000USD | 569,688,000USD | 596,187,000USD | 606,653,000USD | 415,231,000USD | 434,020,000USD | 456,554,000USD | 174,281,000USD |
| Total Liabilities | 180,016,000USD | — | — | — | — | — | — | — |
| Other Current Assets | — | 9,815,000USD | 9,519,000USD | 8,690,000USD | 5,014,000USD | 5,138,000USD | 4,777,000USD | 2,545,000USD |
| Total Liab | — | 191,230,000USD | 214,261,000USD | 217,922,000USD | 37,674,000USD | 33,754,000USD | 36,507,000USD | 261,689,000USD |
| Total Stockholder Equity | — | 378,458,000USD | 381,926,000USD | 388,731,000USD | 377,557,000USD | 400,266,000USD | 420,047,000USD | -87,408,000USD |
| Other Current Liab | — | 8,629,000USD | 12,167,000USD | 69,436,000USD | 6,557,000USD | 4,352,000USD | 7,798,000USD | 5,787,000USD |
| Common Stock | — | 45,000USD | 45,000USD | 45,000USD | 45,000USD | 44,000USD | 44,000USD | 3,000USD |
| Capital Stock | — | 45,000USD | 45,000USD | 45,000USD | 45,000USD | 44,000USD | 44,000USD | 3,000USD |
| Retained Earnings | — | -175,890,000USD | -167,253,000USD | -156,515,000USD | -164,688,000USD | -139,850,000USD | -118,374,000USD | -97,706,000USD |
| Cash | — | 71,605,000USD | 120,722,000USD | 319,989,000USD | 189,311,000USD | 210,045,000USD | 238,196,000USD | 88,242,000USD |
| Cash And Short Term Investments | — | 347,401,000USD | 391,089,000USD | 474,346,000USD | 326,561,000USD | 336,005,000USD | 350,923,000USD | 130,533,000USD |
| Total Current Assets | — | 368,058,000USD | 410,964,000USD | 491,681,000USD | 334,141,000USD | 342,469,000USD | 356,824,000USD | 133,411,000USD |
| Total Current Liabilities | — | 78,165,000USD | 86,931,000USD | 75,282,000USD | 15,127,000USD | 10,638,000USD | 12,849,000USD | 13,231,000USD |
| Current Deferred Revenue | — | 59,763,000USD | 62,269,000USD | — | — | — | — | — |
| Net Debt | — | -48,515,000USD | -97,097,000USD | -295,879,000USD | -164,740,000USD | -185,019,000USD | -212,720,000USD | -63,016,000USD |
| Short Term Debt | — | 2,309,000USD | 2,212,000USD | 2,117,000USD | 2,026,000USD | 1,937,000USD | 1,851,000USD | 1,116,000USD |
| Short Long Term Debt Total | — | 23,090,000USD | 23,625,000USD | 24,110,000USD | 24,571,000USD | 25,026,000USD | 25,476,000USD | 25,226,000USD |
| Long Term Investments | — | 174,691,000USD | 157,569,000USD | 87,212,000USD | 52,633,000USD | 62,242,000USD | 69,866,000USD | 6,979,000USD |
| Short Term Investments | — | 275,796,000USD | 270,367,000USD | 154,357,000USD | 137,250,000USD | 125,960,000USD | 112,727,000USD | 42,291,000USD |
| Net Receivables | — | 10,842,000USD | 10,356,000USD | 8,645,000USD | 2,566,000USD | 1,326,000USD | 1,124,000USD | 333,000USD |
| Accounts Payable | — | 7,464,000USD | 10,283,000USD | 3,729,000USD | 6,544,000USD | 4,349,000USD | 3,200,000USD | 6,128,000USD |
| Property Plant Equipment Net | — | 25,261,000USD | 25,933,000USD | 26,354,000USD | 27,252,000USD | 28,127,000USD | 28,692,000USD | 29,507,000USD |
| Property Plant Equipment Gross | — | 30,034,000USD | 30,285,000USD | 30,414,000USD | 30,968,000USD | 31,453,000USD | 31,621,000USD | 32,048,000USD |
| Accumulated Other Comprehensive Income | — | -569,000USD | 617,000USD | 374,999USD | 176,000USD | 198,000USD | 56,000USD | 176,000USD |
| Common Stock Shares Outstanding | — | 44,758,800shares | 44,258,338shares | 45,602,099shares | 44,165,168shares | 43,937,410shares | 32,383,314shares | 42,002,794shares |
| Non Current Assets Total | — | 201,630,000USD | 185,223,000USD | 114,972,000USD | 81,090,000USD | 91,551,000USD | 99,730,000USD | 40,870,000USD |
| Non Current Liabilities Total | — | 113,065,000USD | 127,330,000USD | 142,640,000USD | 22,547,000USD | 23,116,000USD | 23,658,000USD | 248,458,000USD |
| Non Current Liabilities Other | — | 100,000USD | — | — | 2,000USD | 27,000USD | 33,000USD | 191,000USD |
| Non Currrent Assets Other | — | 176,369,000USD | 816,000USD | 1,406,000USD | 1,205,000USD | 1,182,000USD | 1,172,000USD | 4,384,000USD |
| Net Working Capital | — | 289,893,000USD | 324,033,000USD | 416,399,000USD | 319,014,000USD | 331,831,000USD | 343,975,000USD | 120,180,000USD |
| Unclassified Non Current Assets | — | -174,691,000USD | — | — | — | — | — | — |
| Unclassified Non Current Liabilities | — | 112,965,000USD | 127,330,000USD | 142,640,000USD | 22,545,000USD | 23,089,000USD | 23,625,000USD | 248,267,000USD |
| Unclassified Equity | — | 554,827,000USD | 548,472,000USD | 544,781,001USD | 541,979,000USD | 539,830,000USD | 538,277,000USD | 10,116,000USD |
| Source | 0001193125-26-342328Preliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Total Assets | 596,187,000USD | 456,554,000USD | 130,867,000USD | 36,119,000USD |
| Other Current Assets | 9,519,000USD | 4,777,000USD | 1,419,000USD | 1,283,000USD |
| Total Liab | 214,261,000USD | 36,507,000USD | 169,241,000USD | 80,320,000USD |
| Total Stockholder Equity | 381,926,000USD | 420,047,000USD | -38,374,000USD | -44,201,000USD |
| Other Current Liab | 12,167,000USD | 7,798,000USD | 4,077,000USD | 1,762,000USD |
| Common Stock | 45,000USD | 44,000USD | 3,000USD | 3,000USD |
| Capital Stock | 45,000USD | 44,000USD | 3,000USD | 3,000USD |
| Retained Earnings | -167,253,000USD | -118,374,000USD | -46,576,000USD | -50,756,000USD |
| Cash | 120,722,000USD | 238,196,000USD | 88,483,000USD | 30,607,000USD |
| Cash And Short Term Investments | 391,089,000USD | 350,923,000USD | 88,483,000USD | 30,607,000USD |
| Total Current Assets | 410,964,000USD | 356,824,000USD | 112,678,000USD | 31,890,000USD |
| Total Current Liabilities | 86,931,000USD | 12,849,000USD | 6,914,000USD | 5,543,000USD |
| Current Deferred Revenue | 62,269,000USD | — | — | — |
| Net Debt | -97,097,000USD | -212,720,000USD | -75,917,000USD | -29,897,000USD |
| Short Term Debt | 2,212,000USD | 1,851,000USD | — | 710,000USD |
| Short Long Term Debt Total | 23,625,000USD | 25,476,000USD | 12,566,000USD | 710,000USD |
| Long Term Investments | 157,569,000USD | 69,866,000USD | 0USD | — |
| Short Term Investments | 270,367,000USD | 112,727,000USD | 0USD | — |
| Net Receivables | 10,356,000USD | 1,124,000USD | 22,776,000USD | 0USD |
| Accounts Payable | 10,283,000USD | 3,200,000USD | 2,637,000USD | 3,071,000USD |
| Property Plant Equipment Net | 25,933,000USD | 28,692,000USD | 17,187,000USD | 3,105,000USD |
| Property Plant Equipment Gross | 30,285,000USD | 31,621,000USD | 18,809,000USD | 3,903,000USD |
| Accumulated Other Comprehensive Income | 617,000USD | 56,000USD | — | — |
| Common Stock Shares Outstanding | 44,258,338shares | 37,193,054shares | 19,495,760shares | 19,495,760shares |
| Non Current Assets Total | 185,223,000USD | 99,730,000USD | 18,189,000USD | 4,229,000USD |
| Non Current Liabilities Total | 127,330,000USD | 23,658,000USD | 162,327,000USD | 74,777,000USD |
| Non Currrent Assets Other | 159,290,000USD | 1,172,000USD | 1,002,000USD | 1,124,000USD |
| Net Working Capital | 324,033,000USD | 343,975,000USD | 105,764,000USD | 26,347,000USD |
| Unclassified Non Current Assets | -157,569,000USD | — | — | — |
| Unclassified Non Current Liabilities | 127,330,000USD | 23,625,000USD | 161,781,000USD | 74,694,000USD |
| Unclassified Equity | 548,472,000USD | 538,277,000USD | 8,196,000USD | 6,549,000USD |
| Non Current Liabilities Other | — | 33,000USD | 546,000USD | 83,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -8,637,000USD | -10,738,000USD | 8,173,000USD | -24,838,000USD | -21,476,000USD | -20,668,000USD | -20,523,000USD | -16,440,999USD |
| Depreciation | 421,000USD | 401,000USD | 400,000USD | 400,000USD | 397,000USD | 388,000USD | 364,000USD | 333,000USD |
| Stock Based Compensation | 6,015,000USD | 2,656,000USD | 2,532,000USD | 1,806,000USD | 1,482,000USD | 1,264,000USD | 683,000USD | 628,000USD |
| Other Non Cash Items | 5,829,000USD | -318,000USD | -10,034,000USD | 1,367,000USD | -460,000USD | -323,000USD | 83,000USD | 701,999USD |
| Change To Account Receivables | -486,000USD | -1,711,000USD | -8,494,000USD | 99,000USD | -79,000USD | 40,000USD | -10,000USD | 190,000USD |
| Change In Working Capital | -23,246,000USD | -6,989,000USD | 170,268,000USD | 2,784,000USD | -3,286,000USD | -1,466,000USD | 2,715,000USD | 2,528,000USD |
| Total Cash From Operating Activities | -25,633,000USD | -14,988,000USD | 168,807,000USD | -20,287,000USD | -23,343,000USD | -20,958,000USD | -16,814,000USD | -12,987,000USD |
| Capital Expenditures | -832,000USD | -65,000USD | -13,000USD | -58,000USD | -382,000USD | -612,000USD | -578,000USD | -149,000USD |
| Free Cash Flow | -26,465,000USD | -15,053,000USD | 168,794,000USD | -20,345,000USD | -23,725,000USD | -21,570,000USD | -17,392,000USD | -13,136,000USD |
| Investments | -22,985,000USD | -185,235,000USD | -38,392,000USD | -786,000USD | -4,874,000USD | -133,239,000USD | -24,794,000USD | -12,133,000USD |
| Total Cashflows From Investing Activities | -23,817,000USD | -185,300,000USD | -38,392,000USD | -786,000USD | -4,874,000USD | -133,239,000USD | -24,794,000USD | -12,133,000USD |
| Total Cash From Financing Activities | 333,000USD | 1,021,000USD | 263,000USD | 339,000USD | 66,000USD | 304,151,000USD | -1,322,000USD | 74,952,000USD |
| Change In Cash | -49,117,000USD | -199,267,000USD | 130,678,000USD | -20,734,000USD | -28,151,000USD | 149,954,000USD | -42,930,000USD | 131,172,000USD |
| Begin Period Cash Flow | 120,722,000USD | 320,894,000USD | 189,311,000USD | 210,045,000USD | 238,196,000USD | 89,147,000USD | 132,077,000USD | 82,245,000USD |
| End Period Cash Flow | 71,605,000USD | 121,627,000USD | 319,989,000USD | 189,311,000USD | 210,045,000USD | 239,101,000USD | 89,147,000USD | 131,172,000USD |
| Other Cashflows From Financing Activities | 333,000USD | 1,021,000USD | 263,000USD | 339,000USD | 66,000USD | 1,363,000USD | -1,322,000USD | 74,952,000USD |
| Unclassified Operating Cash Flow | -6,015,000USD | — | -2,532,000USD | -1,806,000USD | — | — | — | — |
| Sale Purchase Of Stock | — | 0USD | -1,000USD | — | 0USD | 0USD | — | — |
| Issuance Of Capital Stock | — | 0USD | 0USD | — | — | 302,788,000USD | -58,000USD | — |
| Other Cashflows From Investing Activities | — | — | 12,500,000USD | — | — | -1,654,000USD | -721,000USD | — |
| Unclassified Investing Cash Flow | — | — | -12,487,000USD | — | — | 2,266,000USD | 1,299,000USD | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | 302,788,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Net Income | -48,879,000USD | -71,798,000USD | 4,180,000USD | -27,676,000USD |
| Depreciation | 1,604,000USD | 1,401,000USD | 848,000USD | 577,000USD |
| Stock Based Compensation | 8,476,000USD | 3,152,000USD | 1,620,000USD | 1,520,000USD |
| Other Non Cash Items | -13,789,000USD | 18,000USD | -46,788,000USD | 530,000USD |
| Change To Account Receivables | -10,185,000USD | -20,000USD | -151,000USD | 0USD |
| Change In Working Capital | 162,777,000USD | 248,000USD | 926,000USD | 1,746,000USD |
| Total Cash From Operating Activities | 110,189,000USD | -67,470,000USD | -38,723,000USD | -23,303,000USD |
| Capital Expenditures | -518,000USD | -2,103,000USD | -2,878,000USD | -1,289,000USD |
| Free Cash Flow | 109,671,000USD | -69,573,000USD | -41,601,000USD | -24,592,000USD |
| Investments | -241,334,000USD | -160,598,000USD | 22,122,000USD | -1,289,000USD |
| Total Cashflows From Investing Activities | -229,352,000USD | -160,598,000USD | 22,122,000USD | -1,289,000USD |
| Total Cash From Financing Activities | 1,689,000USD | 377,781,000USD | 74,520,000USD | 30,051,000USD |
| Sale Purchase Of Stock | -1,000USD | -1,000USD | -1,000USD | — |
| Issuance Of Capital Stock | 0USD | 377,730,000USD | 74,521,000USD | 29,969,000USD |
| Change In Cash | -117,474,000USD | 149,713,000USD | 57,919,000USD | 5,459,000USD |
| Begin Period Cash Flow | 239,101,000USD | 89,388,000USD | 31,469,000USD | 26,010,000USD |
| End Period Cash Flow | 121,627,000USD | 239,101,000USD | 89,388,000USD | 31,469,000USD |
| Other Cashflows From Investing Activities | 12,500,000USD | 22,625,000USD | 25,000,000USD | — |
| Other Cashflows From Financing Activities | 1,689,000USD | 74,994,000USD | 74,521,000USD | 30,051,000USD |
| Unclassified Investing Cash Flow | — | -20,522,000USD | -22,122,000USD | 1,289,000USD |
| Unclassified Financing Cash Flow | — | 302,788,000USD | — | -29,969,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.